22
TITLE: Cytochrome P450 expression system for high-throughput real-time detection of genotoxicity: Application to the study of human CYP1A2 variants  Full Text
AUTHORS: Bernardo Brito Palma; Daniela Moutinho; Philippe Urban; Jose Rueff; Michel Kranendonk;
PUBLISHED: 2016, SOURCE: MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS, VOLUME: 806
INDEXED IN: Scopus WOS CrossRef
23
TITLE: Instability of the Human Cytochrome P450 Reductase A287P Variant Is the Major Contributor to Its Antley-Bixler Syndrome-like Phenotype
AUTHORS: Karen M McCammon; Satya P Panda; Chuanwu W Xia; Jung Ja P Kim; Daniela Moutinho; Michel Kranendonk; Richard J Auchus; Eileen M Lafer; Debashis Ghosh; Pavel Martasek; Rekha Kar; Bettie Sue Masters; Linda J Roman;
PUBLISHED: 2016, SOURCE: JOURNAL OF BIOLOGICAL CHEMISTRY, VOLUME: 291, ISSUE: 39
INDEXED IN: Scopus WOS CrossRef
24
TITLE: Human Sulfotransferase 1A1-Dependent Mutagenicity of 12-Hydroxy-nevirapine: The Missing Link?  Full Text
AUTHORS: Michel Kranendonk; Monica Alves; Pedro Antunes; Jose Rueff;
PUBLISHED: 2014, SOURCE: CHEMICAL RESEARCH IN TOXICOLOGY, VOLUME: 27, ISSUE: 11
INDEXED IN: Scopus WOS CrossRef
25
TITLE: Functional characterization of eight human CYP1A2 variants. the role of cytochrome b5
AUTHORS: Bernardo B Palma; Marta Silva e Sousa; Phillipe Urban; José Rueff; Michel Kranendonk;
PUBLISHED: 2013, SOURCE: Pharmacogenetics and Genomics, VOLUME: 23, ISSUE: 2
INDEXED IN: CrossRef
IN MY: ORCID
26
TITLE: Alkylating Potential of Oxetanes  Full Text
AUTHORS: Rafael Gómez-Bombarelli; Bernardo Brito Palma; Célia Martins; Michel Kranendonk; Antonio S Rodrigues; Emilio Calle; José Rueff; Julio Casado;
PUBLISHED: 2010, SOURCE: Chem. Res. Toxicol. - Chemical Research in Toxicology, VOLUME: 23, ISSUE: 7
INDEXED IN: CrossRef
IN MY: ORCID
27
TITLE: Human Cytochrome P450 1A2: Comprehensive Study of Eight Polymorphic Variants  Full Text
AUTHORS: Bernardo Brito Palma; Marta S E Silva e Sousa; Jeroen Lastdrager; Jose Rueff; Nico P E Vermeulen; Michel Kranendonk;
PUBLISHED: 2009, SOURCE: 11th European Regional ISSX Meeting in DRUG METABOLISM REVIEWS, VOLUME: 41
INDEXED IN: WOS
28
TITLE: Human P450 Reductase Y181D Variant, Molecular Effects of FMN Deficiency  Full Text
AUTHORS: Michel Kranendonk; Chris C Marohnic; Karen McCammon; Bettie Sue S Masters; Jose Rueff;
PUBLISHED: 2009, SOURCE: 11th European Regional ISSX Meeting in DRUG METABOLISM REVIEWS, VOLUME: 41
INDEXED IN: WOS
29
TITLE: Simple and sensitive antimalarial drug screening in vitro and in vivo using transgenic luciferase expressing Plasmodium berghei parasites  Full Text
AUTHORS: Franke-Fayard, B; Djokovic, D; M.W Dooren; Ramesar, J; A.P Waters; M.O Falade; Kranendonk, M; Martinelli, A; Cravo, P; C.J Janse;
PUBLISHED: 2008, SOURCE: International Journal for Parasitology, VOLUME: 38, ISSUE: 14
INDEXED IN: CrossRef
IN MY: ORCID
30
TITLE: Isolation and prevalidation of an Escherichia coli tester strain for the use in mechanistic and metabolic studies of genotoxins  Full Text
AUTHORS: Michel Kranendonk; Margarida Ruas; António Laires; José Rueff;
PUBLISHED: 1994, SOURCE: Mutation Research/Environmental Mutagenesis and Related Subjects, VOLUME: 312, ISSUE: 2
INDEXED IN: CrossRef
IN MY: ORCID
Page 3 of 4. Total results: 32.